Consistently, GSDME protein enhancement and cleavage has been simultaneously observed in the tumors from tumor-bearing mice after intratumoral treatment of ORFV (105 TCID50) (Fig. 3h, i and Supplementary Fig. 6b). This evidence concerns the gene GSDME and neoplasm.